Suven Life Sciences Financial Statements

Suven Life Sciences Nine Monthly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (6.50) (98) 15 8.81
Op profit growth (31) (158) 53.50 27
EBIT growth (28) (153) 55.50 24.40
Net profit growth (23) (176) 41.90 21.30
Profitability ratios (%)        
OPM (594) (803) 31.70 23.70
EBIT margin (569) (734) 32 23.70
Net profit margin (535) (654) 19.80 16
RoCE (57) (21) 24.30 17.10
RoNW (14) (5.20) 4.31 3.45
RoA (13) (4.60) 3.76 2.90
Per share ratios ()        
EPS (5.70) (7.40) 9.72 6.85
Dividend per share -- -- 1.50 1
Cash EPS (6) (7.70) 8.04 5.17
Book value per share 8.49 11.30 60.30 52.40
Valuation ratios        
P/E (12) (2.90) 0.87 1.22
P/CEPS (12) (2.80) 1.05 1.62
P/B 8.30 1.90 0.14 0.16
EV/EBIDTA (12) (2.60) 9.67 14.50
Payout (%)        
Dividend payout -- -- 18.60 17.60
Tax payout (6.90) (11) (37) (29)
Liquidity ratios        
Debtor days 54.60 808 31.30 33.40
Inventory days 1.90 1,766 67.70 59.10
Creditor days (19) (90) (42) (35)
Leverage ratios        
Interest coverage 94 192 (43) (23)
Net debt / equity (0.40) (0.10) 0.01 0.09
Net debt / op. profit 0.52 0.08 0.03 0.48
Cost breakup ()        
Material costs -- -- (25) (28)
Employee costs (137) (121) (9.80) (9.60)
Other costs (557) (782) (34) (39)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 13.50 14.40 625 544
yoy growth (%) (6.50) (98) 15 8.81
Raw materials -- -- (154) (152)
As % of sales -- -- 24.60 27.90
Employee costs (19) (17) (61) (52)
As % of sales 137 121 9.80 9.60
Other costs (75) (113) (212) (210)
As % of sales 557 782 33.90 38.70
Operating profit (80) (116) 198 129
OPM (594) (803) 31.70 23.70
Depreciation (4.30) (4.20) (21) (21)
Interest expense (0.80) (0.60) (4.60) (5.70)
Other income 7.75 14 23.30 21.10
Profit before tax (77) (106) 196 123
Taxes 5.32 12.20 (72) (36)
Tax rate (6.90) (11) (37) (29)
Minorities and other -- -- -- --
Adj. profit (72) (94) 124 87.20
Exceptional items -- -- -- --
Net profit (72) (94) 124 87.20
yoy growth (%) (23) (176) 41.90 21.30
NPM (535) (654) 19.80 16
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (77) (106) 196 123
Depreciation (4.30) (4.20) (21) (21)
Tax paid 5.32 12.20 (72) (36)
Working capital (308) (316) 84 (84)
Other operating items -- -- -- --
Operating cashflow (384) (415) 186 (18)
Capital expenditure (223) (248) 26.80 (27)
Free cash flow (607) (663) 213 (45)
Equity raised 714 807 1,304 1,334
Investments 0.05 (0.10) (22) 22.20
Debt financing/disposal (89) (67) (30) 43.10
Dividends paid -- -- 19.10 12.70
Other items -- -- -- --
Net in cash 17.80 77.20 1,484 1,368
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 49.70 12.70 12.70 12.70
Preference capital -- -- -- --
Reserves 58.40 131 226 755
Net worth 108 143 239 767
Minority interest
Debt 4.76 6.01 2.72 34
Deferred tax liabilities (net) -- 6.86 21.70 56.40
Total liabilities 113 156 264 858
Fixed assets 25.70 24.70 22.40 332
Intangible assets
Investments 0.09 0.05 223 279
Deferred tax asset (net) -- 0.99 1.22 33.10
Net working capital 40.30 115 16.40 185
Inventories 0.14 -- -- 139
Inventory Days 3.79 -- -- 81.40
Sundry debtors 1.76 2.27 2.64 61.50
Debtor days 47.70 57.50 -- 35.90
Other current assets 54 140 54.70 78.70
Sundry creditors (4.20) (5.80) (7.10) (59)
Creditor days 113 146 -- 34.20
Other current liabilities (11) (21) (34) (36)
Cash 46.70 15.10 0.69 28.20
Total assets 113 156 264 858
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2020 Dec-2019 Dec-2018 - -
Gross Sales 11.90 5.75 283 -- --
Excise Duty -- -- -- -- --
Net Sales 11.90 5.75 283 -- --
Other Operating Income -- -- -- -- --
Other Income 6.43 11 21.50 -- --
Total Income 18.40 16.80 305 -- --
Total Expenditure ** 70.30 96.40 248 -- --
PBIDT (52) (80) 56.40 -- --
Interest 0.66 0.32 1.62 -- --
PBDT (53) (80) 54.80 -- --
Depreciation 3.28 3.12 11.10 -- --
Minority Interest Before NP -- -- -- -- --
Tax -- -- 16 -- --
Deferred Tax (5.40) (14) 12.20 -- --
Reported Profit After Tax (51) (69) 15.50 -- --
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest (51) (69) 15.50 -- --
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item (51) (69) 15.50 -- --
EPS (Unit Curr.) (4) (5.40) 1.22 -- --
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 12.70 12.70 12.70 -- --
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) (436) (1,385) 19.90 -- --
PBDTM(%) (442) (1,390) 19.30 -- --
PATM(%) (424) (1,194) 5.48 -- --
Open ZERO Brokerage Demat Account